These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Seroprevalence of 8 oncogenic human papillomavirus genotypes and acquired immunity against reinfection. Wilson L, Pawlita M, Castle PE, Waterboer T, Sahasrabuddhe V, Gravitt PE, Schiffman M, Wentzensen N. J Infect Dis; 2014 Aug 01; 210(3):448-55. PubMed ID: 24569064 [Abstract] [Full Text] [Related]
8. The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice. Khan MJ, Castle PE, Lorincz AT, Wacholder S, Sherman M, Scott DR, Rush BB, Glass AG, Schiffman M. J Natl Cancer Inst; 2005 Jul 20; 97(14):1072-9. PubMed ID: 16030305 [Abstract] [Full Text] [Related]
9. Multiple human papillomavirus infections with high viral loads are associated with cervical lesions but do not differentiate grades of cervical abnormalities. Schmitt M, Depuydt C, Benoy I, Bogers J, Antoine J, Arbyn M, Pawlita M, VALGENT Study Group. J Clin Microbiol; 2013 May 20; 51(5):1458-64. PubMed ID: 23447632 [Abstract] [Full Text] [Related]
11. Smoking is a risk factor for cervical intraepithelial neoplasia grade 3 among oncogenic human papillomavirus DNA-positive women with equivocal or mildly abnormal cytology. McIntyre-Seltman K, Castle PE, Guido R, Schiffman M, Wheeler CM, ALTS Group. Cancer Epidemiol Biomarkers Prev; 2005 May 20; 14(5):1165-70. PubMed ID: 15894667 [Abstract] [Full Text] [Related]
12. Prevalence and distribution of high-risk human papillomavirus genotypes in invasive carcinoma of the uterine cervix in Uruguay. Berois N, De Cremoux P, Mazal D, Sica A, Cedeira M, Caserta B, Barrios E, Osinaga E, Sastre-Garau X. Int J Gynecol Cancer; 2013 Mar 20; 23(3):527-32. PubMed ID: 23392403 [Abstract] [Full Text] [Related]
14. Human papillomavirus 16/18 seroprevalence in unvaccinated women over 30 years with normal cytology and with high grade cervical abnormalities in Australia: results from an observational study. Velentzis LS, Sitas F, O'Connell DL, Darlington-Brown J, Egger S, Sinha R, Banks E, Frazer IH, Canfell K. BMC Infect Dis; 2014 Dec 21; 14():3861. PubMed ID: 25528152 [Abstract] [Full Text] [Related]
15. Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study. Castle PE, Stoler MH, Wright TC, Sharma A, Wright TL, Behrens CM. Lancet Oncol; 2011 Sep 21; 12(9):880-90. PubMed ID: 21865084 [Abstract] [Full Text] [Related]